| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| Gene symbol | COLEC10 | Synonyms | 3MC3, CL-10, CL-34, CLL1 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.12 | dbXrefs | |
| Description | collectin subfamily member 10 | ||||
| GTO ID | GTC2041 |
| Trial ID | NCT03795779 |
| Disease | Hematologic Cancer | Chronic Myeloid Leukemia | Myeloproliferative Neoplasm | Myelodysplastic Syndrome |
| Altered gene | CLL1|CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLL1/CD38 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG141-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||